GET FREE CONSULTATION!
+256 704 292188
Uganda today declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less than four months after the first case was confirmed in the country’s central Mubende district on 20 September 2022. “Uganda put a swift end to the Ebola outbreak by ramping up key control measures such as surveillance, contact tracing and…
An innovation that is addressing procurement constraints is making drug stock-outs and shortage of medical equipment in health facilities in Rwanda a thing of the past. Viebeg Technologies, a venture capital-backed Health Tech company, is helping to expand access to affordable health care in Central and East Africa by aiding healthcare facilities in procuring supplies…
A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis (MDR-TB) than the current options, according to results of a Doctors Without Borders/Médecins Sans Frontières (MSF) study published in the New England Journal of Medicine today. These findings come from MSF’s TB PRACTECAL, the first-ever multi-country, randomized, controlled clinical trial to…
Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with…